- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.08. | Are we about to see a return for the pharma mega-merger? | ||
| 03.08. | ZEUS delivers a bolt of pain to Novo Nordisk | ||
| 31.07. | Datroway joins Trodelvy for frontline TNBC in the EU | ||
| 31.07. | Apnimed IPO raises $192m, as three other biotechs set terms | ||
| 31.07. | Adcomm backs Replimune melanoma drug, despite data concern | ||
| 30.07. | Pfizer cues up vitiligo filing for Litfulo after phase 3 win | ||
| 30.07. | UK patient first in world to get novel lung cancer vaccine | ||
| 30.07. | Sanofi drops two more programmes in R&D clear-out | ||
| 30.07. | Cytokinetics' cardiomyopathy drug cleared for NHS use | ||
| 30.07. | J&J takes $2.58bn option to buy in vivo CAR-T firm Sail | ||
| 30.07. | Lawmakers seek answers from RFK on Gardasil shot settlement | ||
| 30.07. | FDA advisors vote no to Capricor's DMD therapy | ||
| 29.07. | Simple blood test could aid in global TB fight | ||
| 29.07. | Leqembi sales grow again after subcutaneous approvals | ||
| 29.07. | EU first to clear AbbVie's Rinvoq for alopecia areata | ||
| 29.07. | Altimmune alcohol use disorder drug hits the mark in phase 2 | ||
| 29.07. | US judge says Novo Nordisk must face lawsuit over CagriSema | ||
| 28.07. | GSK to quit Stevenage for new R&D site in Cambridge | ||
| 28.07. | HIV resurgence looming as international aid declines | ||
| 28.07. | Severino takes the helm at Sarepta after turbulent spell | ||
| 28.07. | Scribe Therapeutics raises $155m in IPO, as Apnimed pitches for $150m | ||
| 28.07. | Is J&J approaching the end of its talc litigation hangover? | ||
| 27.07. | J&J's oral IL-23 drug backed for psoriasis in EU | ||
| 27.07. | Chris McDonald replaces Vallance as UK science minister | ||
| 27.07. | Outlook finally claims FDA approval for AMD drug |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.